Microbiome report week ending 7-14-18

Microbiome report week ending 7-14-18

Source: 
CP Wire
snippet: 
Assembly is developing live biotherapeutics for  indications that include IBD (ulcerative colitis and Crohn's disease), IBS, immuno-oncology, NASH and metabolic diseases.